FTC’s Crackdown on Pharma Mergers Reflects ‘Tougher’ M&A Environment Under Biden Administration: Lawyer
March 22, 2021
By: Eric Sagonowsky
FiercePharma
Axinn partner Jeny Maier was quoted in the FiercePharma article, "FTC's Crackdown on Pharma Mergers Reflects 'Tougher' M&A Environment Under Biden Administration: Lawyer." This quote also appeared in the April 21, 2021 Forbes article, “After Roaring in 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays and Possible Drug Pricing Legislation.”
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Axinn Earns Top Antitrust Rankings Coast to Coast in GCR 100
Awards & Recognitions
Why Should I Care About Property Controls?
Speaking Engagement
Antitrust
What’s the Score, Your Honor? Conversation With Judge Richard Boulware
Podcast
LCA Renaissance Symposium XIX 2025
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
Japan Competition Law Update
Axinn Viewpoints
Antitrust
